Les angiœdème héréditaires de type III : nouvelle maladie ou nouveau diagnostic ?

详细信息	查看全文 | 推荐本文 |

• 作者：L. Bouillet
• 关键词：Angiœ ; dema ; Bradykinin ; Hageman factor ; Kallikrein
• 刊名：Revue Francaise d'Allergologie et d'Immunologie Clinique
• 出版年：2008
• 期刊代码：239_03357457
• 类别：med
• 出版时间：April 2008
• 卷：48
• 期：3
• 页码：155-158
• 文件大小：339 K

摘要

Current knowledge and key points. – Diseases with a clinical profile close to hereditary angioneurotic edema, but without C1Inh anomaly, have been described recently. It is in fact family cases, concerning only women, where estrogens seem to play a dominant role. Angioedema’s secondary aspects are gathering various pathologies (vasculitis, Gleich’s syndrome, angioedema initiated by physical agents). The role played by some drugs must not be forgotten, mainly angiotensin converting enzyme inhibitors, which are at the origin of angiodema in nearly 0.5%of users.

Future prospect and projects. – Uncontrolled activation of the contact system seems to play a major role in the main part of these angiodemas. The efficiency of the tranexaminic acid (which modulates its activation) is to be taken as evident. The key to the future seems to be the development of plasmin and bradykinin inhibitors.